Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ronald Hunt


  • Director at Iterum Therapeutics Plc (ITRM), 2020-01-23
  • Large Shareholder, Director at Harpoon Therapeutics Inc. (HARP), 2019-06-05
  • Large Shareholder, Director at Neuronetics Inc. (STIM), 2019-04-03
  • Large Shareholder at Irhythm Technologies Inc. (IRTC), 2016-10-25
  • Large Shareholder at Mei Pharma Inc. (MEIP), 2015-03-26
  • Large Shareholder at Versartis Inc. (VSAR), 2014-12-22
  • Large Shareholder, Director at Durata Therapeutics Inc. (DRTX), 2014-05-23
  • Large Shareholder at Chimerix Inc (CMRX), 2014-03-20
  • Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2014-02-21
  • Other at Oxford Immunotec Global Plc (OXFD), 2013-12-03
  • Director, Other at Relypsa Inc (RLYP), 2013-11-21
  • Large Shareholder at World Heart Corp (WHRT), 2012-08-06
  • Other at Icagen Inc (ICGN), 2011-07-29
  • Other at Transcept Pharmaceuticals Inc (TSPT), 2011-07-20
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
HARP $14.00 214,285 Large Shareholder, Director 678,566 2019-02-12 Filing
HARP $14.00 214,286 Large Shareholder, Director 2,242,839 2019-02-12 Filing
ITRM $13.00 384,615 Large Shareholder, Director 384,615 2018-05-30 Filing
ITRM $13.00 278,062 Large Shareholder, Director 1,071,688 2018-05-30 Filing
RLYP $11.00 185,978 Director, Other 2,114,890 2013-11-20 Filing